期刊文献+

P53、Ki67、Bcl-2的表达在胸腺瘤分型中的意义 被引量:2

Significance of P53,Ki67 and Bcl-2 expression in classification of thymoma
下载PDF
导出
摘要 [目的]探讨P53、Ki67、Bcl-2的表达在不同类型胸腺瘤中的意义及其临床特征。[方法]对66例胸腺瘤进行组织学分型。A型9例;AB型11例;B1型13例;B2型10例;B3型10例;C型13例。应用免疫组织化学染色SP法,检测P53、Ki67、Bcl-2在66例不同类型胸腺瘤中表达特征。[结果]在A、AB、B1、B2、B3型及C型胸腺瘤中,P53的表达分别为22.2%、27.2%、23.1%、40.0%、60.0%、84.6%,B2、B3、C型与A、AB、B1型之间差异显著(P<0.05);Ki67高指数(Ⅲ级+Ⅳ级)表达分别为22.2%、18.1%、23.1%、40.0%、70.0%、84.6%,B2、B3、C型与A、AB、B1型之间差异显著(P<0.05);Bcl-2阳性率分别为100.0%、72.7%、23.1%、40.0%、80.0%、69.2%,B1、B2、B3型胸腺瘤呈逐渐增高趋势,存在显著差异性(P<0.05)。[结论]P53、Ki67、Bcl-2的表达在不同类型胸腺瘤中差异显著,有助于判断胸腺瘤良恶性,对临床预后评估有重要参考价值。 [Objective] To study clinic signification detecting expressions of P53, Ki67 and Bcl- 2 in thymoma different types. [ Methods] The 66 cases of thymomas were detected by SP immunohistochemical method including type A 9 cases, type AB 11 cases, type B1 13 cases, type B2 10 cases, type B3 10 cases and type C 13 cases. [ Results] In the thymoma type A, AB, B1, B2, B3, and type C, the expression rates of P53 were 22.2%, 27.2% ,23.1% ,40.0% ,60.0% and 84.6% respectively. The rates of B2, B3 and C types were significantly higher than those of A, AB and B1 types in 66 thymomas. (P 〈 0.05 )The high index (grade Ⅲ and grade Ⅳ) expression rates were 22.2%, 18.1%, 23.1%, 40.0%, 70.0% and 84.6%. The rates of B2, B3 and C types were significantly higher than those of A,AB and B1 types in 66 thymoma. ( P 〈 0.05 )The expression rates of Bcl-2 were 100.0%,72.7%, 23. 1%, 40.0%, 80.0% and 69.2% respectively, there were obvious increasing tendency in B2, B3 and C type, and there were obvious difference. ( P 〈 0.05 ) [ Conclusion] The detection of P53 , Ki67 and Bcl- 2 expression may be helpful to judge malignancy thymoma.
出处 《大连医科大学学报》 CAS 2006年第2期84-86,90,共4页 Journal of Dalian Medical University
关键词 胸腺瘤 P53 KI67 BCL-2 thymoma P53 Bcl- 2 Ki67
  • 相关文献

参考文献9

  • 1Rosai J,Sobin LH.Histological typing of tumours of the thymus.In:World Health Orgnization.International Histological classification of tumors.nd ed[M].Berlin:Springer,1999.
  • 2Muller-Hermelink HK,Marx A.Pathological aspects of malignant and benign thymid[J].Histopathology,1999,35:19-30.
  • 3买世娟,熊敏,宗永生,李智,饶慧兰.胸腺肿瘤组织中EB病毒、细胞增殖和凋亡的检测[J].中华病理学杂志,1999,28(2):89-92. 被引量:7
  • 4Tateyama H,Eimoto T,Tada T,et al.P53 protein expressiong and p53 gene mutation in thymic epithelial tumors.An immunohistochemical and DNA sequencing study [J].Am J Clinpathol,1995,104(4):375.
  • 5Weirich G,Schneider P,Fellbaum C,et al.P53 alterations in thymic epithelial tumours [J].Virchows Arch,1997,431(1):17.
  • 6刘屹立,刘同才,王平,孔垂泽,张铭铮,孙志熙,李芳,李书章,李昕.Ki-67及bcl-2基因产物在肾癌组织中的表达及其意义[J].中华泌尿外科杂志,1999,20(6):329-331. 被引量:8
  • 7De Riese WT,Crabtree WN,Alhoff ER,et al.prognostic significance of Ki67 immynostuning in nonmetastatic renal cell carcinoma[J].J Clin On-col,1993,11:1804-1848.
  • 8Nakopiulou L,Vourlakou C,Zerras A,et al.The prevalence of bcl-2,P53 and Ki67 immunoreactivity transitional cell bladder carcinomas and their clinicopathologic correlates[J].Hun Pathol,1998:29:146-154.
  • 9孙梅,张兴义,邹洪杰,孙亚欣,李东复.细胞周期蛋白D1、Ki-67和bcl-2的表达与CD117阳性的胃肠道间质瘤生物学行为的关系[J].中华病理学杂志,2005,34(12):788-790. 被引量:11

二级参考文献16

  • 1Wu T C,Hum Pathol,1993年,24卷,235页
  • 2Mann R B,Modern Pathol,1992年,5卷,363页
  • 3Zong Y S,中华肿瘤杂志,1992年,14卷,103页
  • 4Chen F F,Hum Pathol,1996年,27卷,1089页
  • 5邹高德,中华泌尿外科杂志,1997年,18卷,329页
  • 6Miettinen M,Lasota J.Gastrointestinal stromal tumors-definition,clinical,histological,immunohistochemical,and molecular genetic features and differential diagnisis.Virchows Archiv,2001,438:1-12.
  • 7Toyoshima F,Moriguchi T,Wada A,et al.Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint.EMBO J,1998,17:2728-2735.
  • 8Miettinen M,EI-Rifai W,Sobin HL,et al.Evaluation of malignancy and prognosis of gastrointestinal stromal tumors:a review.Hum Pathol,2002,33:478-483.
  • 9Rudolph P,Gloeckner K,Parwaresch R,et al.Immunophenotype,proliferation,DNA ploidy,and biological behavior of gastrointestinal stromal tumors:a multivariate clinicopathologic study.Hum Pathol,1998,29:791-800.
  • 10Abdulkader I,Cameselle-Teijeiri J,Gude F,et al.Predictors of malignant behaviour in gastrointestinal stromal tumours:a clinicopathological study of 34 cases.Eur J Surg,2002,168:288-296.

共引文献23

同被引文献29

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部